newsfilter
← Latest News
GlobeNewswire·

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced today